- $2.46m
- $0.79m
- $0.13m
Brief: Organovo Says IIAM Will Provide Co With Donated Organs That Have Not Been Utilized, For Therapeutic Liver Tissue Development Program
U.S. STOCKS ON THE MOVE-Apple, Athenahealth, Apptio, Tobacco companies
Organovo: Jumps on cell and tissue clinical sourcing deal
Brief: Organovo Qtrly Loss Per Share $0.05
Brief: Organovo Holdings Qtrly Net Loss Per Common Share $0.07
Brief: Organovo Reports Q4 Revenue $1.1 Mln
Brief: Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement
Brief: Organovo Holdings- Entered Sales Agreement Where Co May Offer, Sell Shares In 'At Market' Sales Transactions With Offering Price Of Up To $50 Million
Brief: Organovo Holdings Files For Mixed Shelf Offering Of Up To $100 Mln
Brief: Organovo Reports Q3 Loss Per Share Of $0.07
Brief: Organovo Receives Orphan Designation From U.S. FDA For 3D Bioprinted Therapeutic Liver Tissue
Brief: Organovo posts Q3 loss per share $0.09
Brief: Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease
Brief: Organovo says preliminary Q2 revenue $1.3 mln - $1.4 mln
Brief: Organovo says Keith Murphy submitted resignation as chairman of board
Brief: Organovo reports Q1 loss per share $0.10
Brief: Organovo reports CEO transition
Brief: Organovo Q3 loss per share $0.09
Brief: Organovo signs exclusive distributor agreement with Japanese Cosmo Bio